TCM
INSM icon

Teza Capital Management’s Insmed INSM Stock Holding History

Teza Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,984
Closed -$244K – 661
2024
Q1 		$244K Sell
8,984
-1,505
-14% -$42.1K 0.03% 477
2023
Q4 		$325K Buy
+10,489
New +$272K 0.05% 389

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Teza Capital Management's INSM Position: Q2 2024 in Review

Teza Capital Management sold out of Insmed (INSM) in Q2 2024, closing a stake of 8,984 shares — an estimated $244K sold.

Teza Capital Management first reported a position in INSM in Q4 2023 and held it in 2 quarters. The position peaked at $325K in Q4 2023. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

  • Teza Capital Management reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
  • Teza Capital Management sold 8,984 Insmed shares in Q2 2024, an estimated $244K.
  • Teza Capital Management first reported a position in Insmed in Q4 2023 and held it in 2 quarters.
  • Teza Capital Management's Insmed position peaked at $325K in Q4 2023.
  • 378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Teza Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.